ISTH 2020 Congress
Platelet Disorders and von Willebrand Disease » Platelet Function Disorders, Acquired
Theme Navigation
- ISTH 2020 Congress
- Platelet Disorders and von Willebrand Disease
- Platelet Function Disorders, Acquired
- Platelet Disorders and von Willebrand Disease
-
Abstract Number: PB1473
«Aspirin-Like» Platelet Defect Induced by Gabapentin: A Case-Report
-
Abstract Number: PB1481
Assessment of Platelet Function after Shear Stress Simulation Using an ex vivo Model for Extracorporeal Circulation
-
Abstract Number: PB1475
Bleeding Symptoms Associated with Platelet Function Abnormalities on Ibrutinib Therapy
-
Abstract Number: PB1470
Complex Changes in Plasma Associated with Platelet Dysfunction in Trauma Patients
-
Abstract Number: PB1478
Dual Antiplatelet Therapy in One Patient with a Immune GPVI Deficiency
-
Abstract Number: PB1480
Dysregulation of Platelet Serotonin and Platelet 14-3-3-Related Biomarkers in Sudden Infant Death Syndrome
-
Abstract Number: PB1483
First Evidence: Edoxaban Affects TRAP-dependent Platelet Aggregation
-
Abstract Number: PB1482
First Evidence: Rivaroxaban, Apixaban and Edoxaban Reduce Thrombin-Dependent Platelet Aggregation
-
Abstract Number: PB1471
Platelet Dysfunction and Coagulation Activation in Intracerebral Hemorrhage
-
Abstract Number: PB1472
Platelet Purinergic Signaling Regulates Pulmonary Thrombosis in Sickle Cell Disease
-
Abstract Number: PB1479
Quality of Life Today in Patients with Chronic Immune Thrombocytopenic Purpura
-
Abstract Number: PB1477
Severe Platelet Dysfunction in Patient with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL) after Tyrosine Kinase Inhibitor (TKI) Therapy
-
Abstract Number: PB1474
Uremia Induced Pre-Activation Results in Platelet Function Impairment in Chronic Kidney Disease